OKYO
Price
$2.18
Change
-$0.04 (-1.80%)
Updated
Sep 26 closing price
Capitalization
81.99M
66 days until earnings call
ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
4.51M
Interact to see
Advertisement

OKYO vs ROQAF

Header iconOKYO vs ROQAF Comparison
Open Charts OKYO vs ROQAFBanner chart's image
OKYO Pharma
Price$2.18
Change-$0.04 (-1.80%)
Volume$56.16K
Capitalization81.99M
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization4.51M
OKYO vs ROQAF Comparison Chart in %
Loading...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OKYO vs. ROQAF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKYO is a Hold and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (OKYO: $2.18 vs. ROQAF: $0.02)
Brand notoriety: OKYO and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKYO: 53% vs. ROQAF: 100%
Market capitalization -- OKYO: $81.99M vs. ROQAF: $4.51M
OKYO [@Biotechnology] is valued at $81.99M. ROQAF’s [@Biotechnology] market capitalization is $4.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKYO’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • OKYO’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, OKYO is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKYO’s TA Score shows that 6 TA indicator(s) are bullish.

  • OKYO’s TA Score: 6 bullish, 3 bearish.

Price Growth

OKYO (@Biotechnology) experienced а +10.10% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

OKYO is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($82M) has a higher market cap than ROQAF($4.51M). OKYO YTD gains are higher at: 89.582 vs. ROQAF (-57.300).
OKYOROQAFOKYO / ROQAF
Capitalization82M4.51M1,817%
EBITDAN/AN/A-
Gain YTD89.582-57.300-156%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
OKYO
RSI
ODDS (%)
Bullish Trend 3 days ago
37%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
55%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSONX15.830.14
+0.89%
Nuveen International Res Eq R6
EQNAX23.600.19
+0.81%
MFS Equity Income A
CMGIX43.710.25
+0.58%
BlackRock Mid-Cap Growth Equity Instl
GEOSX16.390.08
+0.49%
Pear Tree Essex Environmental Opps Ins
FIFVX26.500.13
+0.49%
Fidelity Advisor Founders I

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-1.80%
XRTX - OKYO
29%
Poorly correlated
-6.98%
ACUT - OKYO
28%
Poorly correlated
N/A
DYN - OKYO
28%
Poorly correlated
+4.53%
NXTC - OKYO
27%
Poorly correlated
-1.38%
MRNA - OKYO
26%
Poorly correlated
-0.49%
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
LYRA - ROQAF
85%
Closely correlated
+1.73%
EYPT - ROQAF
37%
Loosely correlated
+5.38%
RIGL - ROQAF
22%
Poorly correlated
-0.24%
RYTM - ROQAF
21%
Poorly correlated
+0.02%
OKYO - ROQAF
3%
Poorly correlated
-1.80%
More